Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases

International Journal of Oncology

Volumn 47, Issue 6, 2015, Pages 2264-2275

  Cacan, Ercan ^a   Greer, Susanna F ^a   Garnett Benson, Charlie ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Co stimulatory molecules; Death receptors; DNA methylation; Histone acetylation; Radiation

Indexed keywords

CD137 LIGAND; DEATH RECEPTOR 5; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FAS LIGAND; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; DNA METHYLTRANSFERASE; HISTONE; HISTONE DEACETYLASE;

ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; ENZYME REGULATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RADIATION DOSE; ACETYLATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; RADIATION RESPONSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ACETYLATION; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; RADIATION, IONIZING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84982077224     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3192     Document Type: Article

References (78)

1. Szumiel I: Ionising radiation-induced oxidative stress, epigenetic changes and genomic instability: The pivotal role of mitochondria. Int J Radiat Biol 91:1-12, 2015.
2. Agassi AM, Myslicki FA, Shulman JM, Rotterman Y, Dosoretz DE, Fernandez E, Mantz CA and Finkelstein SE: The promise of combining radiation therapy and immunotherapy: Morbidity and toxicity. Future Oncol 10:2319-2328, 2014.
3. Finkelstein SE, Salenius S, Mantz CA, Shore ND, Fernandez EB, Shulman J, Myslicki FA, Agassi AM, Rotterman Y, DeVries T, et al: Combining immunotherapy and radiation for prostate cancer. Clin Genitourin Cancer 13:1-9, 2015.
4. Garnett-Benson C, Hodge JW and Gameiro SR: Combination regimens of radiation therapy and therapeutic cancer vaccines: Mechanisms and opportunities. Semin Radiat Oncol 25:46-53, 2015.
5. Di Leonardo A, Linke SP, Clarkin K and Wahl GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8:2540-2551, 1994.
6. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP and Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198, 2003.
7. Ostling O and Johanson KJ: Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123:291-298, 1984.
8. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121, 2001.
9. Kumari A, Cacan E, Greer SF and Garnett-Benson C: Turning T cells on: Epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells. J Immunother Cancer 1:17, 2013.
10. Ifeadi V and Garnett-Benson C: Sublethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways. PLoS One 7:e31762, 2012.
11. Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S and Hodge JW: Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget 5:403-416, 2014.
12. Garnett CT, Palena C, Chakraborty M, Tsang KY, Schlom J and Hodge JW: Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64:7985-7994, 2004.
13. Kim R, Emi M and Tanabe K: Cancer immunoediting from immune surveillance to immune escape. Immunology 121:1-14, 2007.
14. Bubeník J: MHC class I down-regulation: Tumour escape from immune surveillance (Review) ? Int J Oncol 25:487-491, 2004.
15. Lee H, Kim JH, Yang SY, Kong J, Oh M, Jeong DH, Chung JI, Bae KB, Shin JY, Hong KH, et al: Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. J Cancer Res Clin Oncol 136:1445-1452, 2010.
16. French LE and Tschopp J: Defective death receptor signaling as a cause of tumor immune escape. Semin Cancer Biol 12:51-55, 2002.
17. Hopkins-Donaldson S, Ziegler A, Kurtz S, Bigosch C, Kandioler D, Ludwig C, Zangemeister-Wittke U and Stahel R: Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ 10:356-364, 2003.
18. Croft M, So T, Duan W and Soroosh P: The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229:173-191, 2009.
19. Tu TH, Kim CS, Nam-Goong IS, Nam CW, Kim YI, Goto T, Kawada T, Park T, Yoon Park JH, Ryoo ZY, et al: 4-1BBL signaling promotes cell proliferation through reprogramming of glucose metabolism in monocytes/macrophages. FEBS J 282:1468-1480, 2015.
20. Eun SY, Lee SW, Xu Y and Croft M: 4-1BB ligand signaling to T cells limits T cell activation. J Immunol 194:134-141, 2015.
21. Guicciardi ME and Gores GJ: Life and death by death receptors. FASEB J 23:1625-1637, 2009.
22. Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG and de Jong S: Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas. J Pathol 200:327-335, 2003.
23. Driscoll PC: Structural studies of death receptors. Methods Enzymol 545:201-242, 2014.
24. Gronbaek K, Hother C and Jones PA: Epigenetic changes in cancer. APMIS 115:1039-1059, 2007.
25. Jin B, Yao B, Li JL, Fields CR, Delmas AL, Liu C and Robertson KD: DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. Cancer Res 69:7412-7421, 2009.
26. Müller BM, Jana L, Kasajima A, Lehmann A, Prinzler J, Budczies J, Winzer KJ, Dietel M, Weichert W and Denkert C: Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer-overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. BMC Cancer 13:215, 2013.
27. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054, 2003.
28. Esteller M: Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 8:286-298, 2007.
29. Nguyen CT, Gonzales FA and Jones PA: Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: Correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29:4598-4606, 2001.
30. Cacan E, Ali MW, Boyd NH, Hooks SB and Greer SF: Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance. PLoS One 9:e87455, 2014.
31. Ali MW, Cacan E, Liu Y, Pierce JY, Creasman WT, Murph MM, Govindarajan R, Eblen ST, Greer SF and Hooks SB: Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells. PLoS One 8:e60185, 2013.
32. Ramakrishnan V: Histone structure and the organization of the nucleosome. Annu Rev Biophys Biomol Struct 26:83-112, 1997.
33. Kouzarides T: Chromatin modifications and their function. Cell 128:693-705, 2007.
34. Kuo MH and Allis CD: Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20:615-626, 1998.
35. Stypula-Cyrus Y, Damania D, Kunte DP, Cruz MD, Subramanian H, Roy HK and Backman V: HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS One 8:e64600, 2013.
36. Millard CJ, Watson PJ, Celardo I, Gordiyenko Y, Cowley SM, Robinson CV, Fairall L and Schwabe JW: Class I HDACs share a common mechanism of regulation by inositol phosphates. Mol Cell 51:57-67, 2013.
37. Esteller M: CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21:5427-5440, 2002.
38. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB and Schuebel KE: CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404:1003-1007, 2000.
39. Jin B, Li Y and Robertson KD: DNA methylation: Superior or subordinate in the epigenetic hierarchy? Genes Cancer 2:607-617, 2011.
40. Venza M, Visalli M, Catalano T, Fortunato C, Oteri R, Teti D and Venza I: Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma. Biochem Biophys Res Commun 441:743-750, 2013.
41. Maecker HL, Yun Z, Maecker HT and Giaccia AJ: Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. Cancer Cell 2:139-148, 2002.
42. Jazirehi AR and Arle D: Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: An attractive approach to bypass melanoma immunotherapy resistance. Am J Clin Exp Immunol 2:55-74, 2013.
43. Mueller S, Yang X, Sottero TL, Gragg A, Prasad G, Polley MY, Weiss WA, Matthay KK, Davidoff AM, DuBois SG, et al: Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms. Cancer Lett 306:223-229, 2011.
44. Antwih DA, Gabbara KM, Lancaster WD, Ruden DM and Zielske SP: Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics 8:839-848, 2013.
45. Kaeser MD, Pebernard S and Iggo RD: Regulation of p53 stability and function in HCT116 colon cancer cells. J Biol Chem 279:7598-7605, 2004.
46. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990.
47. Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, et al: Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol 93:303-318, 2009.
48. Watson CJ, O'Kane H, Maxwell P, Sharaf O, Petak I, Hyland PL, O'Rouke D, McKnight J, Canning P and Williamson K: Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer. Int J Oncol 40:645-654, 2012.
49. Bae JH, Kim JG, Heo K, Yang K, Kim TO and Yi JM: Identification of radiation-induced aberrant hypomethylation in colon cancer. BMC Genomics 16:56, 2015.
50. Johnstone RW: Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 1:287-299, 2002.
51. Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, Miyakawa I and Koeffler HP: Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin Cancer Res 10:1141-1149, 2004.
52. Lyko F and Brown R: DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97:1498-1506, 2005.
53. Yu Y, Teng Y, Liu H, Reed SH and Waters R: UV irradiation stimulates histone acetylation and chromatin remodeling at a repressed yeast locus. Proc Natl Acad Sci USA 102:8650-8655, 2005.
54. Pollack BP, Sapkota B and Boss JM: Ultraviolet radiationinduced transcription is associated with gene-specific histone acetylation. Photochem Photobiol 85:652-662, 2009.
55. Ji S, Tian Y, Lu Y, Sun R, Ji J, Zhang L and Duan S: Irradiationinduced hippocampal neurogenesis impairment is associated with epigenetic regulation of bdnf gene transcription. Brain Res 1577:77-88, 2014.
56. Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH and Liu K: Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol 302:G1405-G1415, 2012.
57. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature genetics 31:141-149, 2002.
58. Thaler R, Spitzer S, Karlic H, Berger C, Klaushofer K and Varga F: Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells. Biochem Pharmacol 85:173-185, 2013.
59. Li W, Xia D, Wang Y, Li Y, Xue Y, Wu X and Ye Z: Relationship between aberrant methylation of FAS promoter and biological behavior of bladder urothelial carcinoma. J Huazhong Univ Sci Technol Med Sci 31:794-798, 2011.
60. Kurita S, Higuchi H, Saito Y, Nakamoto N, Takaishi H, Tada S, Saito H, Gores GJ and Hibi T: DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8. Cancer Sci 101:1431-1439, 2010.
61. Lee KH, Lim SW, Kim HG, Kim DY, Ryu SY, Joo JK, Kim JC and Lee JH: Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma. Langenbecks Arch Surg 394:661-670, 2009.
62. Chaudhry MA and Omaruddin RA: Differential DNA methylation alterations in radiation-sensitive and -resistant cells. DNA Cell Biol 31:908-916, 2012.
63. Aypar U, Morgan WF and Baulch JE: Radiation-induced epigenetic alterations after low and high LET irradiations. Mutat Res 707:24-33, 2011.
64. Kimura H and Shiota K: Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 278:4806-4812, 2003.
65. Robertson KD: DNA methylation and human disease. Nat Rev Genet 6:597-610, 2005.
66. Fuks F: DNA methylation and histone modifications: Teaming up to silence genes. Curr Opin Genet Dev 15:490-495, 2005.
67. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB and Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354, 2000.
68. Giacinti L, Vici P and Lopez M: Epigenome: A new target in cancer therapy. Clin Ter 159:347-360, 2008.
69. Ng JM and Yu J: Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci 16:2472-2496, 2015.
70. Lin PC, Lin JK, Lin CH, Lin HH, Yang SH, Jiang JK, Chen WS, Chou CC, Tsai SF and Chang SC: Clinical relevance of plasma DNA methylation in colorectal cancer patients identified by using a genome-wide high-resolution array. Ann Surg Oncol: Dec. 4, 2014 (Epub ahead of print).
71. Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Si J, et al: ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One 6:e16916, 2011.
72. Vaish V, Khare T, Verma M and Khare S: Epigenetic therapy for colorectal cancer. Methods Mol Biol 1238:771-782, 2015.
73. Lee SC, Cheong HJ, Kim SJ, Yoon J, Kim HJ, Kim KH, Kim SH, Kim HJ, Bae SB, Kim CK, et al: Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines. Anticancer Res 31:3385-3394, 2011.
74. Marks PA, Miller T and Richon VM: Histone deacetylases. Curr Opin Pharmacol 3:344-351, 2003.
75. Tampakis A, Tampaki EC, Nebiker CA and Kouraklis G: Histone deacetylase inhibitors and colorectal cancer: What is new? Anticancer Agents Med Chem 14:1220-1227, 2014.
76. Chakraborty M 1, Wansley EK, Carrasquillo JA, Yu S, Paik CH, Camphausen K, Becker MD, Goeckeler WF, Schlom J and Hodge JW: The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res 14:4241-4249, 2008.
77. Palayoor ST, John-Aryankalayil M, Makinde AY, Falduto MT, Magnuson SR and Coleman CN: Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation. Mol Cancer Res 12:1002-1015, 2014.
78. Khare S and Verma M: Epigenetics of colon cancer. Methods Mol Biol 863:177-185, 2012.